# Monitor Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/monitor

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.monitorcorp.ai/
- Total disclosed funding: $8.3M
- Latest round: Series B (Oct 2, 2024)
- Investors on record: 6

## About

Monitor Corporation, based in South Korea, specializes in medical AI technologies, providing advanced solutions that enhance diagnostic processes in healthcare settings.Founded in 2018 and headquartered in Seoul, South Korea, Monitor Corporation develops AI-driven diagnostic tools. The company has executed 4 deals, with its most recent deal occurring on October 2, 2024. It raised KRW 7 billion in a Series B funding round led by Premier Partners, UTC Investment, and HB Investment. The CEO is Kyong Lee.Monitor Corporation primarily offers MONCAD, an advanced medical AI solution designed to enhance diagnostic processes in medical imaging. MONCAD utilizes various imaging modalities to support healthcare professionals in accelerating diagnostics and providing second opinions. The platform focuses on improving lung cancer diagnostics through its LCT product and supports Automated Breast Ultrasound Systems with its ABS offering. The company caters to hospitals, diagnostic imaging centers, and healthcare providers integrating AI into their workflows across several regions.Monitor Corporation's revenue model is based on subscription access to its MONCAD products, engaging clients under a B2B framework. Healthcare institutions pay a set fee that may include tiered pricing based on service range or user count. Partnerships with medical facilities enable tailored MONCAD implementations to meet specific diagnostic requirements, emphasizing continuous improvement and a sustainable revenue stream through client engagement.In October 2024, Monitor Corporation raised KRW 7 billion in Series B funding to facilitate its expansion into global markets, targeting Japan, the US, Europe, and Singapore. The funds will support the development of new products aimed at enhancing diagnostic capabilities and broadening the company's market presence.

## Funding rounds

- Series B, Oct 2, 2024, $5.3M — HB Investment, UTC Investment, Premier Partners
- Series A, Dec 20, 2021, $2.5M — UTC Investment, Premier Partners
- Seed, Apr 15, 2019 — Naver D2 Startup Factory
- Seed, Oct 1, 2018, $0.5M — Bluepoint Partners, Korea Tech Incubator for Startup

## Investors

- Bluepoint Partners (https://capitalatlas.ai/funds/bluepoint-partners) — Seed
- Korea Tech Incubator for Startup — Seed
- Naver D2 Startup Factory (https://capitalatlas.ai/funds/naver-d2-startup-factory) — Seed
- UTC Investment (https://capitalatlas.ai/funds/utc-investment) — Series A, Series B
- Premier Partners (https://capitalatlas.ai/funds/premier-partners) — Series A, Series B
- HB Investment (https://capitalatlas.ai/funds/hb-investment) — Series B